Authors:
Markowska, J
Fischer, N
Warchol, JB
Fischer, Z
Citation: J. Markowska et al., Detection of Chlamydia trachomatis infection in women with CIN and invasive carcinoma. Controversial results of different methods, EUR J GYN O, 22(2), 2001, pp. 134-136
Authors:
Bar, JK
Harlozinska, A
Sedlaczek, P
Kasiak, J
Markowska, J
Citation: Jk. Bar et al., Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infectionin cervical carcinomas and cervical dysplasias, ANTICANC R, 21(2A), 2001, pp. 1001-1006
Authors:
Markowska, J
Wilkoszarska, J
Emerich, J
Debniak, J
Popiela, A
Panszczak, M
Kornafel, J
Rossochacka, B
Fisher, Z
Goluda, M
Malecki, P
Citation: J. Markowska et al., Factors influencing period of time between negative second-look laparotomyand ovarian carcinoma recurrence. Multicenter study in Poland, EUR J GYN O, 21(2), 2000, pp. 164-167
Authors:
Van Dalen, A
Favier, J
Baumgartner, L
Hasholzner, U
De Bruijn, H
Dobbler, D
Dombi, VH
Fink, D
Giai, M
Mcging, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Bowman, A
Einarsson, R
Citation: A. Van Dalen et al., Serum levels of CA 125 and TPS during treatment of ovarian cancer, ANTICANC R, 20(6D), 2000, pp. 5107-5108
Authors:
van Dalen, A
Favier, J
Burges, A
Hasholzner, U
de Bruijn, HWA
Dobler-Girdziunaite, D
Dombi, VH
Fink, D
Giai, M
McGing, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Bowman, A
Einarsson, R
Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients, GYNECOL ONC, 79(3), 2000, pp. 444-450
Authors:
Zygmunt, A
Madry, R
Markowska, J
Fischer, Z
Citation: A. Zygmunt et al., Estimation of the usefulness of neoplastic markers TPS and CA 125 in diagnosis and monitoring of ovarian cancer, EUR J GYN O, 20(4), 1999, pp. 298-301
Authors:
Van Dalen, A
Favier, J
Baumgartner, L
Hasholzner, U
De Bruijn, H
Dobbler, D
Dombi, VH
Fink, D
Giai, M
McGing, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Einarsson, R
Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients, ANTICANC R, 19(4A), 1999, pp. 2523-2526
Citation: A. Zygmunt et al., Significance of tissue polypeptide specific antigen (TPS) in diagnosis andmonitoring of treatment in ovarian cancer, EUR J GYN O, 19(5), 1998, pp. 484-486